Ashton Tweed Connection Vol. 2 No. 3

Featuring PricewaterhouseCoopers’ Annual Global CEO Survey for 2015

Volume 2, Number 3

Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.


	Stay Connected: Special Targeted News Go beyond the news… Get more focused information about your industry and hiring trends. Click now to enhance your subscription.

Coaching New CEOs to Best Build Business

When a first time CEO of a new biotech company wanted guidance with commercialization strategy, he turned to Ashton Tweed. The new CEO had completed the initial fundraising and wanted to keep the company virtual in the early-stage of clinical development…

13 Vital Traits of Successful Entrepreneurs

There is a group of traits that successful businesses have in common, and it’s no coincidence. In today’s world of entrepreneurship, the competition is fierce, especially within the realm of the life sciences. Do you have what it takes?

2015 US CEO SURVEY – PWC

In PwC’s Annual Global CEO Survey, CEOs claimed they were looking to the US for business growth in 2015. For the first time in five years, business leaders rate the US as their most important market for overseas growth.

The top 15 pharma companies by 2014 revenue

Every year, FiercePharma ranks the top pharmaceutical companies by revenue. This year however, due to some interesting changes towards the bottom of the list, FiercePharma expanded their list to the top 15 companies.
For the first time ever, a biotech company has knocked a Big Pharma company from the top 10.

Outlook for the medical device industry in 2015

The 2015 Medical Device Industry Survey was conducted by Emergo from December 2014 to January 2015, with over 5,400 participants. Based on survey results, the global medical device industry seems stable, but different aspects of the business, such as pricing, regulatory, and reimbursement, have become more challenging.

A Wild Ride: Biotech Financial and M&A Trends 2014

Peter Young, President and Managing Director of Young & Partners, shares details from their “Biotech Strategic, M&A, and Financial Trends Report” for 2014. Here he examines 2014’s business, M&A, and debt and equity financing trends and predicts biotech’s future outlook.

Top 10 U.S. Biopharma Clusters

The same 10 regions top this year’s Top 10 U.S. Biopharma Clusters List as last year’s GEN List, but the top seven regions have shifted positions. The recovering venture capital market is one reason for these shifts. Another is the rise of NIH funding, which is currently one-third higher than last year’s.

Maximizing Pharma Partnerships: Dos And Don’ts From Industry Experts

In the life sciences industry, the most common type of partnership is pharma partnering with pharma. Life Science Leader assembled a panel of experts at the Outsourced Pharma West Conference & Exhibition to answer how these partnerships should be executed.

Biosimilars: Finding the Right Path to Differentiation

For those planning to market a biosimilar, their strategies might need some tweaking. Marketing a biosimilar presents a unique and contradictory challenge: Success depends on proving similarity, but you’ve got to differentiate to win. PharmaExec suggests a stepwise approach.

Drug & Device Makers Hit with More Securities Fraud Lawsuits

Shareholders often file lawsuits against companies alleging securities fraud. However, last year 38 such lawsuits were filed against drug makers and biotechs, which was twice as many as the year before according to Dechert law firm, which conducted the analysis.